KMDA Q4 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q4 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$36M-19.8% YoY

Gross Profit

$14M39.6% margin

Operating Income

$3M7.6% margin

Net Income

$5M13.9% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

-4.0%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$2M

Stock-Based Comp.

$373,000

Balance Sheet

Total Assets

$355M

Total Liabilities

$111M

Stockholders' Equity

$244M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$45M	-19.8%
Gross Profit	$14M	$15M	-5.7%
Operating Income	$3M	$4M	-30.9%
Net Income	$5M	$3M	+71.8%